A nurse is instructing a client who has a new prescription for a daily dose of lovastatin extended release. Which of the following information should the nurse include in the teaching?

A. Peripheral edema: Peripheral edema is not a commonly reported adverse effect of paroxetine.

It is more commonly associated with medications such as calcium channel blockers and certain antihypertensive agents.
B. Alopecia: Alopecia, or hair loss, is not a commonly reported adverse effect of paroxetine. Hair loss is more commonly associated with certain chemotherapy agents and other medications.
C. Drowsiness: Drowsiness is a common side effect of paroxetine and other selective serotonin reuptake inhibitors (SSRIs). Clients should be advised to monitor for drowsiness, especially when starting the medication or adjusting the dosage. Drowsiness can affect activities such as driving or operating machinery and may indicate the need for dosage adjustment or medication change.
D. Tinnitus: Tinnitus, or ringing in the ears, is not a commonly reported adverse effect of paroxetine. It is more commonly associated with medications such as certain antibiotics (e.g., aminoglycosides) and high-dose aspirin.

A. To assess compatibility of the verapamil with newly ordered medications: Verapamil is a calcium channel blocker used to treat hypertension, angina, and arrhythmias. It has potential interactions with many other medications due to its effects on cardiac conduction and blood
pressure. Therefore, consulting the pharmacist is important to assess compatibility and potential drug interactions when new medications are prescribed.
B. To request a change in the dosage of the verapamil: Changing the dosage of verapamil may require a healthcare provider's order rather than consultation with a pharmacist.
C. To verify the frequency of administration of the verapamil: The frequency of administration of verapamil is typically determined by the healthcare provider and documented in the prescription. The pharmacist's role may involve dispensing the medication as prescribed but not verifying the frequency unless there are discrepancies.
D. To report the client's refusal to take the verapamil: Reporting the client's refusal to take the medication should be communicated to the healthcare provider for further assessment and
intervention. The pharmacist's role is primarily related to medication dispensing and ensuring appropriate use rather than addressing client refusals.